Kukje Pharma, Samil Pharmaceutical & Wooridul Pharmaceutical in R&D expense growth rate in 1st quarter

When it comes to this 1^st quarter’s average R&D expenses growth rate compared to the same quarter of the last year, KOSPI listed pharmaceutical companies had an increase, but pharmaceutical companies in the KOSDAQ had a decrease. Both of the groups recorded about 8% in the R&D expense ratio to sales.

According to the Yakup Shinmoon’s(www.yakup.com) analysis result of R&D expenses spent by 35 K...